Home › Major Depressive Disorder › NCT04061148
Near Infrared Spectroscopy (NIRS) for Assessment of Depression
Clinical Testing of Near Infrared Spectroscopy (NIRS) for Quantitative Assessment of Depression
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * All subjects who sign informed consent. * Controls: Volunteers over 18 years of age who are not depressed. * Patients over 18 years of age with a diagnosis of Major Depressive Disorder, receiving clinical therapy at SFVAMC. Exclusion Criteria: * Subjects who cannot sign informed consent. * Exclusion criteria for control subjects: 1.Depression 2.Anxiety, psychotic, substance abuse, mood and personality disorders 3.Major neurocognitive disorders such as Alzheimer's disease and other dementias 4.Neurologic disorders with anatomic lesions including traumatic brain injury, stroke, tumor and arteriovenous malformation * Exclusion criteria for depressed patients: 1.Psychotic disorders like schizophrenia 2.Major neurocognitive disorders such as Alzheimer's disease and other dementias 3.Neurologic disorders with anatomic lesions including traumatic brain injury, stroke, tumor and arteriovenous malformation 4.Not receiving clinical therapy for depression at SFVAMC'
About the study
Develop a NIRSIT testing protocol that can be administered in the diagnostic setting and reliably distinguishes the symptoms and severity of depression, with the help of repeated measure (up to five visits per subject) comparison of patients being treated for Major Depressive Disorder with control, non-depressed subjects.
What is being tested
- NIRSIT (device)
Sponsor: University of California, San Francisco · Participants: 90 · Started: Jan 4, 2019
Contact the study team
- Anusha Badathala, MBBS · Phone: 4152214810
- Arthur Wallace, MD, PhD · Phone: 4152214810
Official record on ClinicalTrials.gov — NCT04061148
Locations in the U.S.
| California | San Francisco Veterans Affairs Medical Center, San Francisco |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.